RAMM Pharma Corp. announced the appointment of José Roldan as interim-Chief Financial Officer of the Company, effective immediately. Mr. Roldan succeeds Mr. Guillermo Delmonte who is currently on medical leave.

Mr. Roldan is a Public Accountant specializing in audits of financial and commercial institutions. He has extensive experience in the cannabis space coupled with knowledge of central bank regulations and International Financial Reporting Standards. Prior to joining RAMM, Mr. Roldan worked as a senior auditor with KPMG Uruguay for six years.